GSK announces decision to license anti-cancer patents to Medicines Patent Pool, by Balaji Subramanian

Saúde Global

SpicyIP – Global pharma major GlaxoSmithKline has announced a change in policy that will doubtless benefit large portions of the patient population in low- and middle-income countries. In a statement on its website today, the company announced that it will not seek patent protection in Least Developed Countries and Low Income Countries. Further, it has announced that it will a more open licensing policy in Lower Middle Income Countries that will allow generic players to enter the market before the expiry of GSK’s patents.

Most importantly, however, GSK has expressed a commitment to license its oncology patents to the Medicines Patent Pool, a UN-backed initiative to improve access to medicine that has seen success in combating the AIDS epidemic and other communicable diseases. Seeking to build on this success by expanding the MPP to cancer treatment, GSK has proposed to license its anti-cancer drug patents to the Pool.


Ver o post original 190 mais palavras


Deixe um comentário

Preencha os seus dados abaixo ou clique em um ícone para log in:

Logotipo do

Você está comentando utilizando sua conta Sair /  Alterar )

Foto do Google+

Você está comentando utilizando sua conta Google+. Sair /  Alterar )

Imagem do Twitter

Você está comentando utilizando sua conta Twitter. Sair /  Alterar )

Foto do Facebook

Você está comentando utilizando sua conta Facebook. Sair /  Alterar )


Conectando a %s